ANI Pharmaceuticals, Inc. (ANIP) is a publicly traded Healthcare sector company. As of August 27, 2026, ANIP trades at $73.52 with a market cap of $1.71B and a P/E ratio of 15.30. ANIP moved -1.41% today. Year to date, ANIP is -6.27%; over the trailing twelve months it is -19.99%. Its 52-week range spans $52.74 to $99.50. Analyst consensus is strong buy with an average price target of $110.83. Rallies surfaces ANIP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
6 analysts cover ANIP: 0 strong buy, 5 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $110.83.
| Metric | Value |
|---|---|
| Price | $73.52 |
| Market Cap | $1.71B |
| P/E Ratio | 15.30 |
| EPS | $4.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.50 |
| 52-Week Low | $52.74 |
| Volume | 237.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $978.38M |
| Net Income | $108.31M |
| Gross Margin | 0.00% |
6 analysts cover ANIP: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.83.